Healthcare -
Biotechnology - NASDAQ - US
$ 26.5
0.607 %
$ 2.22 B
Market Cap
-5.79
P/E
BEAM - LONG-TERM DEBT
Long-term Debt BEAM - Beam Therapeutics Inc.
160 M
LAST VALUE
8.91%
2 YEAR CAGR
0.00%
5 YEAR CAGR
0.00%
10 YEAR CAGR